In vitro effects of suramin on Trypanosoma cruzi

International Journal of Antimicrobial Agents

Volumn 31, Issue 3, 2008, Pages 282-286

  Bisaggio, Danielle Frias Ribeiro ^a   Adade, Camila Marques ^b   Souto Padrón, Thaïs ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Parasite host cell interaction; Suramin; Trypanosoma cruzi; Ultrastructure

Indexed keywords

SURAMIN;

AMASTIGOTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CONTROLLED STUDY; DRUG ACTIVITY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

ANIMALS; MICROSCOPY, ELECTRON, TRANSMISSION; SURAMIN; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 39149112770     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.11.001     Document Type: Article

References (15)

1. De Souza W. Cell biology of Trypanosoma cruzi. Int Rev Cytol 86 (1984) 197-283
2. Urbina J.A., and Docampo R. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol 19 (2003) 494-501
3. Voogd T.E., Vansterkenburg E.L., Wilting J., and Janssen L.H. Recent research on the biological activity of suramin. Pharmacol Rev 45 (1993) 177-203
4. Zhang Y.L., Keng Y.F., Zhao Y., Wu L., and Zhang Z.Y. Suramin is an active site-directed, reversible, and tight-binding inhibitor of protein-tyrosine phosphatases. J Biol Chem 273 (1998) 12281-12287
5. Bisaggio D.F.R., Peres-Sampaio C.E., Meyer-Fernandes J.R., and Souto-Padrón T. Ecto-ATPase activity on the surface of Trypanosoma cruzi and its possible role in the parasite-host cell interaction. Parasitol Res 91 (2003) 273-282
6. Soldani P., Pellegrini A., Gesi M., Lenzi P., and Paparelli A. Suramin-induced ultrastructural changes in the testis of albino rats. Exp Toxicol Pathol 48 (1996) 299-305
7. Kaur M., Reed E., Sartor O., Dahut W., and Figg W.D. Suramin's development: what did we learn?. Invest New Drug 20 (2002) 209-219
8. Vansterkenburg E.L.M., Coppens I., Wilting J., Bos O.J., Fischer M.J., Janssen L.K.H., et al. The uptake of the trypanocidal drug suramin in combination with low-density lipoproteins by Trypanosoma brucei and its possible mode of action. Acta Trop 54 (1993) 237-250
9. Bisaggio D.F.R., Campanati L., Pinto R.C.V., and Souto-Padrón T. Effect of suramin on trypomastigote forms of Trypanosoma cruzi: changes on cell motility and on the ultrastructure of the flagellum-cell body attachment region. Acta Trop 98 (2006) 162-175
10. Seah S. The effect of suramin on experimental Trypanosoma cruzi infection in mice. J Trop Med Hyg 73 (1970) 170-171
11. Hawking F. Suramin: with special reference to onchocerciasis. Adv Pharmacol Chemother 15 (1978) 289-322
12. Pal A., Hall B.S., and Field M.C. Evidence for a non-LDL-mediated entry route for the trypanocidal drug suramin in Trypanosoma brucei. Mol Biochem Parasitol 122 (2002) 217-221
13. Chanez A.-L., Hehl A.B., Engstler M., and Schneider A. Ablation of the single dynamin of T. brucei blocks mitochondrial fission and endocytosis and leads to a precise cytokinesis arrest. J Cell Sci 119 (2006) 2968-2974
14. Hawking F., and Sen A.B. The trypanocidal action of homidium, quinapyramine and suramin. Br J Pharmacol Chemother 15 (1960) 567-570
15. Filardi L.S., and Brener Z. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans R Soc Trop Med Hyg 81 (1987) 755-759